Walsh J P, Clarke I J
Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia.
Endocrinology. 1996 Sep;137(9):3640-8. doi: 10.1210/endo.137.9.8756528.
A reduction in endogenous opioid inhibition (disinhibition) of GnRH secretion is thought to be permissive for the preovulatory GnRH/LH surge. There are no published studies of the effects of highly specific opioid receptor agonists on the LH surge in any species, and the relative importance of the opioid receptor subtypes mu, delta and kappa in the mechanism of disinhibition is unknown. In sheep, attempts to block the LH surge with opiates have been largely unsuccessful, and there is little evidence for reduced opioid inhibition during the GnRH/LH surge. The opioid receptor subtypes regulating PRL secretion in sheep are also unknown. Conscious, ovariectomized ewes with permanent third ventricular cannulae were injected with estradiol benzoate (EB) 50 micrograms or oil im (t = 0 h). In this model, EB elicits a time-delayed surge in LH secretion after 13-18 h. Jugular venous blood was sampled at half hourly intervals between-2 and 0 h and 10 and 26 h. From 12-20 h, infusions were made into the third ventricle of either the highly specific mu-agonist DAGO (10, 20 or 40 nmol/h), the delta-agonist DPDPE (40 nmol/h), the kappa-agonist U50488 (40 nmol/h) or saline (vehicle). In oil-treated animals (n = 4-6), DAGO infusion at 20 and 40 nmol/h reduced plasma LH whereas DPDPE or U50488 had no effect. In EB-treated animals (n = 6), DAGO (40 nmol/h) delayed the LH surge (mean +/- SEM time to surge onset 21.4 +/- 0.3 h vs. 14.0 +/- 0.4 h in controls, P < 0.0001). DAGO at 10 nmol/h did not alter surge onset and at 20 nmol/h had variable effects. DPDPE or U50488 did not affect LH surge timing or amplitude. All doses of DAGO increased plasma PRL, whereas DPDPE and U50488 had no effect. We conclude that, in ovariectomized ewes, activation of opioid mu-receptors, but not delta- or kappa-receptors, inhibits GnRH secretion, can block the estrogen-induced GnRH/LH surge and increases PRL secretion. The results are consistent with the disinhibition hypothesis.
内源性阿片类物质对促性腺激素释放激素(GnRH)分泌的抑制作用减弱(去抑制)被认为是排卵前GnRH/LH峰出现的前提条件。目前尚无关于高度特异性阿片受体激动剂对任何物种LH峰影响的已发表研究,且阿片受体亚型μ、δ和κ在去抑制机制中的相对重要性尚不清楚。在绵羊中,用阿片类药物阻断LH峰的尝试大多未成功,几乎没有证据表明在GnRH/LH峰期间阿片类物质的抑制作用减弱。调节绵羊催乳素(PRL)分泌的阿片受体亚型也不清楚。对有意识的、双侧卵巢切除且带有永久性第三脑室插管的母羊,肌肉注射50微克苯甲酸雌二醇(EB)或油剂(时间t = 0小时)。在此模型中,EB在13 - 18小时后引发LH分泌的延迟峰。在-2至0小时以及10至26小时之间,每隔半小时采集颈静脉血样。在12至20小时期间,向第三脑室内注入高度特异性的μ-激动剂DAGO(10、20或40纳摩尔/小时)、δ-激动剂DPDPE(40纳摩尔/小时)、κ-激动剂U50488(40纳摩尔/小时)或生理盐水(溶剂)。在油剂处理的动物(n = 4 - 6)中,以20和40纳摩尔/小时的速度注入DAGO可降低血浆LH水平,而DPDPE或U50488则无此作用。在EB处理的动物(n = 6)中,40纳摩尔/小时的DAGO延迟了LH峰(达到峰起始的平均±标准误时间为21.4±0.3小时,而对照组为14.0±0.4小时,P < 0.0001)。10纳摩尔/小时的DAGO未改变峰起始时间,20纳摩尔/小时的DAGO作用则不一致。DPDPE或U50488不影响LH峰的时间或幅度。所有剂量的DAGO均增加了血浆PRL水平,而DPDPE和U50488则无此作用。我们得出结论,在双侧卵巢切除的母羊中,阿片μ-受体的激活而非δ-或κ-受体的激活会抑制GnRH分泌,可阻断雌激素诱导的GnRH/LH峰并增加PRL分泌。这些结果与去抑制假说一致。